TechNavio today launched its report, Global Monoclonal Antibodies Market 2011-2015, based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”The development of personalized medicines has become a major trend in the Global Monoclonal Antibodies market. As the biological make-up of every person is different, the same medicine cannot be used to treat the same disease in different patients. This is because the cause of the same disease might be different in different patients. For instance, there are many causes of breast cancer. One of the main causes of breast cancer is a high concentration of an abnormal form of the growth factor Her2. In 2004, Roche, a leader in the development of personalized medicines, produced a genetically-engineered drug (a monoclonal antibody) to block the action of this growth factor.”
According to the report, one of the key drivers is the increasing prevalence of cancer. Monoclonal antibodies are more effective in the treatment of cancer than pharmaceutical drugs and chemotherapies. Hence, the worldwide increase in the prevalence of cancer has increased the revenue generation of the Global Monoclonal Antibodies market.
Further, the report reveals that one of the major challenges in the market is the patent expiry of top-selling drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-monoclonal-antibodies-market-201…
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio